摘要 |
Disclosed are compounds which have PDE9 inhibitory activity and are useful as the active ingredient of therapeutics and/or preventives for urine collection disorder, urination disorder, bladder/urinary tract diseases and so on. As the results of studies on compounds having PDE9 inhibitory activity and being useful as the active ingredient of therapeutics and/or preventives for urine collection disorder, urination disorder, bladder/urinary tract diseases and so on, it is confirmed that an imidazoquinoxaline compound or a triazoloquinoxaline compound has PDE9 inhibitory activity. The aforesaid imidazoquinoxaline compound or triazoloquinoxaline compound has PDE9 inhibitory activity and is usable as preventives and/or therapeutics for urine collection disorder, urination disorder, bladder/urinary tract diseases and so on. |
申请人 |
ASTELLAS PHARMA INC.;KAIZAWA, HIROYUKI;SUGITA, MARI;AZAMI, HIDENORI;SEO, RYUSHI;NOMURA, TAKAHO;YAMAMOTO, SATOSHI;YAMAMOTO, HIROFUMI;TSUCHIYA, KAZUYUKI;KUBOTA, HIDEKI;KAMIJO, KAZUNORI |
发明人 |
KAIZAWA, HIROYUKI;SUGITA, MARI;AZAMI, HIDENORI;SEO, RYUSHI;NOMURA, TAKAHO;YAMAMOTO, SATOSHI;YAMAMOTO, HIROFUMI;TSUCHIYA, KAZUYUKI;KUBOTA, HIDEKI;KAMIJO, KAZUNORI |